New · CUSIP 23282W605 · who reports it, how much, and how much it matters to them
57 of the 720 hedge fund managers we track reported shares of Cytokinetics Inc (Nasdaq: CYTK) on Form 13F for 30 June 2026. Between them they reported USD 1.9bn. The largest position belongs to Avoro Capital Advisors, at USD 426m. The manager with the most riding on it is Sarissa Capital Management, where it is 10.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors1 fund on PPLI.com | USD 426m | 3.8% |
| 2 | RTW Investments2 funds on PPLI.com | USD 244m | 2.1% |
| 3 | Polar Capital LLP26 funds on PPLI.com | USD 192m | 0.5% |
| 4 | POINT72 Asset Management17 funds on PPLI.com | USD 135m | 0.1% |
| 5 | Armistice Capital1 fund on PPLI.com | USD 102m | 1.3% |
| 6 | Holocene Advisors2 funds on PPLI.com | USD 98m | 0.2% |
| 7 | D. E. Shaw & Co.15 funds on PPLI.com | USD 89m | 0.0% |
| 8 | Melqart Asset Management (UK)3 funds on PPLI.com | USD 65m | 6.2% |
| 9 | Balyasny Asset Management25 funds on PPLI.com | USD 61m | 0.1% |
| 10 | Deep Track Capital1 fund on PPLI.com | USD 60m | 0.9% |
| 11 | Citadel Advisors32 funds on PPLI.com | USD 55m | 0.0% |
| 12 | Marshall Wace LLP84 funds on PPLI.com | USD 38m | 0.0% |
| 13 | Two Sigma Investments35 funds on PPLI.com | USD 27m | 0.0% |
| 14 | Exoduspoint Capital Management7 funds on PPLI.com | USD 21m | 0.1% |
| 15 | Walleye Capital8 funds on PPLI.com | USD 20m | 0.1% |
| 16 | Sarissa Capital Management6 funds on PPLI.com | USD 19m | 10.9% |
| 17 | Sphera Funds Management1 fund on PPLI.com | USD 19m | 2.4% |
| 18 | Baker Bros. Advisors2 funds on PPLI.com | USD 18m | 0.1% |
| 19 | PFM Health Sciences3 funds on PPLI.com | USD 16m | 1.4% |
| 20 | Rock Springs Capital Management2 funds on PPLI.com | USD 16m | 0.8% |
| 21 | Dafna Capital Management6 funds on PPLI.com | USD 15m | 2.8% |
| 22 | Kingdon Capital Management7 funds on PPLI.com | USD 13m | 1.4% |
| 23 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 12m | 0.6% |
| 24 | Cinctive Capital Management5 funds on PPLI.com | USD 12m | 0.4% |
| 25 | Aquatic Capital Management3 funds on PPLI.com | USD 11m | 0.4% |
| 26 | Freestone Grove Partners1 fund on PPLI.com | USD 9.8m | 0.1% |
| 27 | Millennium Management6 funds on PPLI.com | USD 9.3m | 0.0% |
| 28 | Burkehill Global Management5 funds on PPLI.com | USD 8.5m | 0.3% |
| 29 | Boxer Capital Management1 fund on PPLI.com | USD 8.5m | 0.6% |
| 30 | Tudor Investment Corporation10 funds on PPLI.com | USD 7.9m | 0.0% |
| 31 | Capricorn Fund Managers8 funds on PPLI.com | USD 7m | 0.5% |
| 32 | HighVista Strategies27 funds on PPLI.com | USD 6.6m | 1.5% |
| 33 | Artia Global Partners1 fund on PPLI.com | USD 6m | 1.1% |
| 34 | Boothbay Fund Management2 funds on PPLI.com | USD 5.8m | 0.1% |
| 35 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 5.6m | 0.3% |
| 36 | Exome Asset Management2 funds on PPLI.com | USD 5.1m | 3.2% |
| 37 | Verition Fund Management3 funds on PPLI.com | USD 4.7m | 0.0% |
| 38 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4.5m | 0.0% |
| 39 | Dark Forest Capital Management2 funds on PPLI.com | USD 3.1m | 0.2% |
| 40 | LMR Partners2 funds on PPLI.com | USD 3m | 0.0% |
| 41 | Palo Alto Investors6 funds on PPLI.com | USD 2.7m | 0.4% |
| 42 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.6m | 0.0% |
| 43 | Orbimed Advisors1 fund on PPLI.com | USD 2.2m | 0.0% |
| 44 | Moore Capital Management7 funds on PPLI.com | USD 2.1m | 0.0% |
| 45 | Landscape Capital Management4 funds on PPLI.com | USD 2.1m | 0.1% |
| 46 | J. Goldman & Co.1 fund on PPLI.com | USD 1.5m | 0.0% |
| 47 | Brevan Howard Capital Management39 funds on PPLI.com | USD 1m | 0.0% |
| 48 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 897,000 | 0.1% |
| 49 | Carlson Capital17 funds on PPLI.com | USD 767,000 | 0.2% |
| 50 | Persistent Asset Partners10 funds on PPLI.com | USD 455,000 | 0.1% |
| 51 | The Quarry1 fund on PPLI.com | USD 346,000 | 0.0% |
| 52 | CIBC Asset Management69 funds on PPLI.com | USD 324,000 | 0.0% |
| 53 | Oxford Asset Management LLP2 funds on PPLI.com | USD 242,000 | 0.1% |
| 54 | Magnetar Financial93 funds on PPLI.com | USD 241,000 | 0.0% |
| 55 | Squarepoint Ops7 funds on PPLI.com | USD 226,000 | 0.0% |
| 56 | Panoramic Capital4 funds on PPLI.com | USD 213,000 | 0.1% |
| 57 | Bayforest Capital1 fund on PPLI.com | USD 183,000 | 0.2% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Sarissa Capital Management | USD 19m | 10.9% |
| 2 | Melqart Asset Management (UK) | USD 65m | 6.2% |
| 3 | Avoro Capital Advisors | USD 426m | 3.8% |
| 4 | Exome Asset Management | USD 5.1m | 3.2% |
| 5 | Dafna Capital Management | USD 15m | 2.8% |
| 6 | Sphera Funds Management | USD 19m | 2.4% |
| 7 | RTW Investments | USD 244m | 2.1% |
| 8 | HighVista Strategies | USD 6.6m | 1.5% |
| 9 | PFM Health Sciences | USD 16m | 1.4% |
| 10 | Kingdon Capital Management | USD 13m | 1.4% |
Cytokinetics Inc trades under the symbol CYTK on the Nasdaq. Its CUSIP, the code used on Form 13F, is 23282W605.
57 of the 720 hedge fund managers PPLI.com tracks reported Cytokinetics Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 426m), RTW Investments (USD 244m), Polar Capital LLP (USD 192m), POINT72 Asset Management (USD 135m) and Armistice Capital (USD 102m).
57 managers in our coverage reported it, and between them they run 690 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Sarissa Capital Management, where the position was 10.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Cytokinetics Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.